Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ERBB3-L
i
Other names:
ERBB3, HER3, LCCS2, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2065
Related biomarkers:
Expression
Mutation
CNA
Others
‹
ERBB3 mutation (6)
ERBB3 G284R (2)
ERBB3 V659E (2)
ERBB3 E952Q (1)
ERBB3 R103G (1)
ERBB3 V104L (1)
ERBB3 V104M (1)
ERBB3 mutation + HER-2 mutation (1)
ERBB3 L755S (0)
ERBB3 R135C (0)
ERBB3 mutation (6)
ERBB3 G284R (2)
ERBB3 V659E (2)
ERBB3 E952Q (1)
ERBB3 R103G (1)
ERBB3 V104L (1)
ERBB3 V104M (1)
ERBB3 mutation + HER-2 mutation (1)
ERBB3 L755S (0)
ERBB3 R135C (0)
›
Associations
(1)
News
Trials
Filter by
Latest
almost2years
Molecular and clinical portrait of HER2-low invasive lobular carcinomas. (PubMed, Mod Pathol)
In conclusion, HER2-low ILCs exhibit their own particularities, both on clinical-pathological and molecular levels. Our findings call for larger multicenter validation studies.
almost 2 years ago
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3)
|
HER-2 positive • HER-2 overexpression • HER-2 negative • ERBB3 mutation • ERBB3-L
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.